MMIT / Evaluate
Based in USA
Data / Analytics Specialist
intelligence provider
Services
MMIT is united with other market-leading pharmaceutical solutions providers—Citeline, Evaluate, Panalgo and The Dedham Group—under our parent company, Norstella. Together, we fuel industry innovation, helping our clients connect the dots from pipeline to patient at every step of the drug development life cycle.
In the News
- Kantar Debuts Post-Launch Evaluation Tool
- Kantar Launches Early-Stage Innovation AI Solution
- Pharma Market Modeller J+D Forecasting Acquired
- Pharma Firms Norstella and Citeline to Merge
- Pharma Intelligence Firm MMIT/Evaluate Acquires Panalgo
- Evaluate Buys Black Swan Analysis
- Brokers Views on General Insurers Service